
BCTX P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.62
Average-0.6670
Median-0.6800
Minimum-0.7100
Maximum-0.5900
-0.62
Past Month-0.04 (6.90%)
The P/E ratio for BCTX is -0.62 as of Jun 13, 2025. This represents a decrease of -11.43% compared to its 12-month average P/E ratio of -0.7. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
BriaCell Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
BriaCell Therapeutics ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing BriaCell Therapeutics to industry peers.
BriaCell Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
BriaCell Therapeutics ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing BriaCell Therapeutics to industry peers.
BCTX P/E Ratio Insights
See BriaCell Therapeutics ’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BCTX
Order type
Buy in
Order amount
Est. shares
0 shares
BCTX P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.47 | -0.69 |
May 1, 2025 | $4.10 | -0.82 |
Apr 1, 2025 | $3.47 | -0.69 |
Mar 3, 2025 | $3.25 | -0.24 |
Feb 3, 2025 | $5.04 | -0.38 |
Jan 2, 2025 | $8.70 | -0.66 |
BCTX End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.62 | -3.12% |
2024 | -0.64 | -81.07% |
2023 | -3.38 | — |
FAQs About BriaCell Therapeutics (BCTX) P/E ratio
The latest P/E ratio of BCTX is -0.62, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
BriaCell Therapeutics ’s last 12-month average P/E ratio is -0.7, compared to its current P/E ratio of -0.62. This reflects a decrease of -11.43%.
BriaCell Therapeutics ’s current P/E ratio of -0.62 is lower than its last 12-month average P/E of -0.7. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
BriaCell Therapeutics ’s average P/E ratio over the last 3 years is -0.99. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
BriaCell Therapeutics ’s average P/E ratio over the last 5 years is -0.6. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.